110 results
Page 2 of 6
8-K
EX-99.1
qfl0dqk1
4 May 23
Bicycle Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
7:30am
8-K
EX-99.1
euwuu13ftvsom9
3 Apr 23
Bicycle Therapeutics Enhances Leadership Team with Key Appointments
7:05am
8-K
EX-99.1
qm47et9nb4r dwujuvs
8 Nov 22
Bicycle Therapeutics Announces First Patient Dosed in BT8009 Phase II Expansion Cohorts and Provides Program Update
7:07am
8-K
EX-99.1
fxu2rbsp88 a77
3 Nov 22
Bicycle Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
7:08am
8-K
EX-99.1
wmz75fywgqifauml
7 Sep 22
Bicycle Therapeutics Announces BT5528 Phase I Dose Escalation Results in Patients with Advanced Solid Tumors
7:03am
8-K
EX-99.1
ny6k88h1no6zf
4 Aug 22
Bicycle Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
7:03am
8-K
EX-99.1
pzot1bc0f
12 Jul 22
Bicycle Therapeutics Announces Further Expansion of Genentech Immuno-Oncology Collaboration
4:00pm
8-K
EX-99.1
0vbjytt7 qocopah9
5 May 22
Bicycle Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update
7:06am
8-K
EX-99.2
ty7mezrtqk
12 Apr 22
Bicycle Therapeutics Announces Interim BT8009 Phase I Clinical Trial Results at the 2022 AACR Annual Meeting
4:14pm
8-K
EX-99.1
mpweh38i
12 Apr 22
Bicycle Therapeutics Announces Interim BT8009 Phase I Clinical Trial Results at the 2022 AACR Annual Meeting
4:14pm